These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6240662)

  • 21. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of migraine and cluster headache.
    Peatfield RC; Rose FC
    Practitioner; 1981 Sep; 225(1359):1321-5. PubMed ID: 7312791
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current therapeutic possibilities in neurology].
    Uldry PA
    Rev Med Suisse Romande; 1992 Jul; 112(7):629-34. PubMed ID: 1496214
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of migraine and cluster headache.
    Rose FC; Peatfield RC
    Panminerva Med; 1982; 24(2):85-7. PubMed ID: 7145460
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutics of disordered movement.
    Sears ES
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J; Thorsen K; Munkvad I
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment.
    Tolosa ES
    Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195
    [No Abstract]   [Full Text] [Related]  

  • 28. Newer drug therapies for headache.
    Diamond S; Medina JL
    Postgrad Med; 1980 Jul; 68(1):125-9, 133-4, 137-8 passim. PubMed ID: 7393781
    [No Abstract]   [Full Text] [Related]  

  • 29. Lithium treatment of meniere's disease. Results of a double-blind cross-over trial.
    Thomsen J; Bech P; Geisler A; Prytz S; Rafaelsen OJ; Vendsborg P; Zilstorff K
    Acta Otolaryngol; 1976; 82(3-4):294-6. PubMed ID: 790893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of haloperidol in the treatment of extrapyramidal compulsive movement].
    Kivalo E; Weckman N
    Nervenarzt; 1970 Nov; 41(11):567-9. PubMed ID: 4249744
    [No Abstract]   [Full Text] [Related]  

  • 32. Amantadine in Huntington's disease: open-label video-blinded study.
    Lucetti C; Gambaccini G; Bernardini S; Dell'Agnello G; Petrozzi L; Rossi G; Bonuccelli U
    Neurol Sci; 2002 Sep; 23 Suppl 2():S83-4. PubMed ID: 12548355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to treat migraine.
    Peatfield R
    Br J Hosp Med; 1984 Feb; 31(2):142-4. PubMed ID: 6697051
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial.
    Vestergaard P; Baastrup PC; Petersson H
    Acta Psychiatr Scand; 1977 Sep; 56(3):183-8. PubMed ID: 143188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study on the treatment of dyskinesia by L-stepholidine].
    Le W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):335-7, 381-2. PubMed ID: 2700694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-tryptophan in neuropsychiatric disorders: a review.
    Sandyk R
    Int J Neurosci; 1992; 67(1-4):127-44. PubMed ID: 1305630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Abnormal movements induced by psychotropic drugs].
    Rondot P; Bathien N
    Encephale; 1979; 5(1):41-8. PubMed ID: 477589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric aspects of abnormal movement disorders.
    Flinn D; Bazzell W
    Brain Res Bull; 1983 Aug; 11(2):153-61. PubMed ID: 6138131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrabenazine and movement disorders.
    Asher SW; Aminoff MJ
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.